By Mill Chart
Last update: Dec 26, 2023
Our stock screening tool has identified RESMED INC (NYSE:RMD) as a strong dividend contender with robust fundamentals. NYSE:RMD exhibits commendable financial health and profitability, all while offering a sustainable dividend. Let's delve into each aspect below.
An integral part of ChartMill's stock analysis is the Dividend Rating, which spans from 0 to 10. This rating evaluates diverse dividend factors, including yield, historical data, growth, and sustainability. NYSE:RMD has received a 7 out of 10:
ChartMill employs its own Health Rating for stock assessment. This rating, ranging from 0 to 10, is calculated by examining various liquidity and solvency ratios. In the case of NYSE:RMD, the assigned 7 reflects its health status:
ChartMill's Profitability Rating offers a unique perspective on stock analysis, providing scores from 0 to 10. These ratings consider a wide range of profitability metrics and margins, both in comparison to industry peers and on their own merits. For NYSE:RMD, the assigned 8 is a significant indicator of profitability:
More Best Dividend stocks can be found in our Best Dividend screener.
Check the latest full fundamental report of RMD for a complete fundamental analysis.
This is not investing advice! The article highlights some of the observations at the time of writing, but you should always make your own analysis and invest based on your own insights.
212.91
+1.42 (+0.67%)
Find more stocks in the Stock Screener
Uncovering Dividend Opportunities with RESMED INC (NYSE:RMD).
Curious about the market action on Tuesday? Dive into the US markets to explore the gap up and gap down stocks in the S&P500 index during today's session.
A fundamental analysis of (NYSE:RMD): Is RESMED INC (NYSE:RMD) suited for quality investing?